Effect of Dabigatran on Coagulation Parameters in Patients Undergoing Elective Orthopaedic Surgery.

Trial Profile

Effect of Dabigatran on Coagulation Parameters in Patients Undergoing Elective Orthopaedic Surgery.

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Aug 2016

At a glance

  • Drugs Dabigatran etexilate (Primary)
  • Indications Thromboembolism
  • Focus Pharmacodynamics
  • Most Recent Events

    • 07 Apr 2011 Actual end date (Apr 2011) added as reported by ClinicalTrials.gov.
    • 07 Apr 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 06 May 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top